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Abstract
As a group, poxviruses have been shown to infect a wide variety of animal species. Howev-
er, there is individual variability in the range of species able to be productively infected. In
this study, we observed that ectromelia virus (ECTV) does not replicate efficiently in cul-
tured rabbit RK13 cells. Conversely, vaccinia virus (VACV) replicates well in these cells.
Upon infection of RK13 cells, the replication cycle of ECTV is abortive in nature, resulting in
a greatly reduced ability to spread among cells in culture. We observed ample levels of
early gene expression but reduced detection of virus factories and severely blunted produc-
tion of enveloped virus at the cell surface. This work focused on two important host range
genes, named E3L and K3L, in VACV. Both VACV and ECTV express a functional protein
product from the E3L gene, but only VACV contains an intact K3L gene. To better under-
stand the discrepancy in replication capacity of these viruses, we examined the ability of
ECTV to replicate in wild-type RK13 cells compared to cells that constitutively express E3
and K3 from VACV. The role these proteins play in the ability of VACV to replicate in RK13
cells was also analyzed to determine their individual contribution to viral replication and
PKR activation. Since E3L and K3L are two relevant host range genes, we hypothesized
that expression of one or both of themmay have a positive impact on the ability of ECTV to
replicate in RK13 cells. Using various methods to assess virus growth, we did not detect
any significant differences with respect to the replication of ECTV between wild-type RK13
compared to versions of this cell line that stably expressed VACV E3 alone or in combina-
tion with K3. Therefore, there remain unanswered questions related to the factors that limit
the host range of ECTV.
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Introduction
Ectromelia virus (ECTV; also referred to as “mousepox virus”) is a double-stranded DNA virus
in the Poxviridae family. ECTV typically infects mice through abrasions in the skin [1]. Follow-
ing initial replication at the site of infection, the virus disseminates to multiple organs over the
course of several days [2]. Among the mice that survive the initial infection, characteristic pock
lesions manifest on the skin [2,3] in a similar fashion to the disease manifestations of humans
infected with variola virus (VARV), the causative agent of smallpox [4].
Vaccinia virus (VACV) is the best studied of all identified poxviruses and was used success-
fully in the global effort to eliminate circulating VARV. As with VARV and VACV, cross-im-
munity exists between ECTV and VACV [5,6]. Yet, despite a high degree of sequence identity
between these two viruses [7], the courses of infection are quite distinct. While mice may be in-
cidental hosts of VACV or even serve as reservoirs of the virus in the wild [8,9], it is fatal only
under certain experimental conditions and routes of infection. In contrast, ECTV infection of
susceptible mice (e.g. BALB/c strain) typically results in death even with a very low initial inoc-
ulum. Moreover, replication of VACV is restricted to the site of infection after cutaneous inoc-
ulation of mice [10], which is quite dissimilar from the infection course of ECTV.
As a group, poxviruses have been shown to infect a wide variety of animal species. However,
at the level of individual members of this family, there is a profound variability in the host spe-
cies range. Recently, there have been advances in our knowledge of poxvirus host range mecha-
nisms [11–13] but overall the underlying molecular basis of these phenomena remains only
partially understood. There have been about 12 different host range genes or gene families
identified that contribute to poxvirus host range [14]. Interestingly, cowpox virus has the
broadest host range of all known poxviruses and also contains the largest number (*26–27
genes) of these host range genes [12]. In terms of the viruses examined in this study, VACV
and ECTV possess 13 and 15 different intact host range genes, respectively [12]. The focus of
this work is on the host range genes E3L and K3L (gene names based upon the nomenclature
of the VACV-Copenhagen strain).
Both ECTV and VACV possess a gene of the E3L family, which encodes for a protein with
an amino-terminal Z-DNA-binding domain and a carboxy-terminal double-stranded RNA
(dsRNA)-binding domain [12,15]. The E3 protein of VACV has been shown to inhibit activa-
tion of protein kinase R (PKR), which is most likely a result of its ability to bind to dsRNA and
prevent PKR homodimerization [16]. E3L can be an important host range gene since its dele-
tion renders some poxviruses unable to replicate in cells derived from certain animal species
(e.g. VACV with a deletion of E3L can no longer replicate in human HeLa or African green
monkey Vero cells [17,18]). The E3L gene between VACV (Western Reserve) and ECTV
(Moscow) shares 93% sequence identity [poxvirus.org]. The majority of the amino acid
changes are found within the amino-terminal Z-DNA-binding domain but there are also some
differences located in the dsRNA-binding domain [19]. It is possible that these variations in
the amino acid sequence could affect the functionality of E3 within infected cells [20–23].
The protein encoded by the K3L gene is a molecular mimic of the eukaryotic translation ini-
tiation factor 2 alpha subunit (eIF2α) and acts to dampen the downstream effects of activated
PKR [24]. Many poxviruses encode for a protein that falls within the K3L family, which sug-
gests that this method of immune evasion is important during infection. Interestingly, ECTV
does not encode a predicted functional version of K3 because its open reading frame contains a
premature stop codon with deletions comprising residues previously reported to be essential
for PKR inhibition [12,19,25].
As reported previously, we observed that ECTV does not replicate efficiently in cultured
rabbit cells, such as RK13 [26]. Conversely, VACV replicates well in rabbit-derived cell lines.
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In this work, we sought to understand the reasons behind this discrepancy in more detail. We
examined the ability of ECTV to replicate in wild-type RK13 cells compared to cells that had
been engineered to stably express the VACV versions of E3L and K3L. Since these are two sig-
nificant host range genes, we hypothesized that one or both of them may have a positive impact
on ECTV’s ability to replicate in RK13 cells.
Materials and Methods
Cells and culture methods
European rabbit cell line RK13 (ATTC# CCL-37) and its derivatives RK13+E3L [27], RK13+
E3L+K3L [27], and BSC1 cells (ATTC# CCL-26) were cultured in Dulbecco's Modified Eagle
Medium (DMEM; Life Technologies) supplemented with 5% fetal bovine serum (FBS; Gemini
BioProducts), and penicillin-streptomycin (Gemini BioProducts). RK13+E3L cells were grown
in media supplemented with 500 μg/mL G418 (Gemini BioProducts). RK13+E3L+K3L cells
were grown in media supplemented with 300 μg/mL zeocin (Life Technologies) and 500 μg/mL
G418 (Gemini BioProducts). All cell lines were maintained at 37°C incubators (5% CO2) and
split when cells reached approximately 80% confluency.
Viruses and infections
The following viruses were used during the course of this work: wild-type ECTV (Moscow
strain), ECTV (Moscow strain) expressing GFP [28], VACV (Western Reserve strain) express-
ing GFP (BEI resources NR-624), wild-type VACV (Copenhagen strain), VACVΔE3L (Copen-
hagen background), VACVΔK3L (Copenhagen background), and VACVΔE3LΔK3L
(Copenhagen background). The mutant VACV strains, kindly provided by Bertram Jacobs,
were constructed using homologous recombination techniques and express green fluorescent
protein (GFP); more detailed information concerning these virus can be found in the previous-
ly published report by Brennan, et al [29].
With respect to wild-type VACV (Copenhagen), VACVΔE3L, VACVΔK3L, and VACV-
ΔE3LΔK3L, infections were performed in duplicate on confluent monolayers of RK13 wild-
type or RK13+E3L+K3L cells in six-well plates at a low initial multiplicity of infection (MOI =
0.01). Following one hour of incubation, the inoculum was removed, and the cells were washed
twice with 1x PBS and replaced in complete media. Virus lysates were collected*30 hours
post infection and subjected to three freeze-thaw cycles. Each virus titer was quantified using a
standard serial dilution plaque assay on RK13+E3L+K3L cells and staining with crystal violet.
For single-cycle growth curves, cells were seeded into six-well plates and confluent mono-
layers were infected (MOI = 5) for one hour. After one hour, the infection media was removed,
the cells were rinsed twice with 1x PBS, and then incubated with fresh complete medium. Sam-
ples were collected at various times post-infection and stored at −80°C. To release infectious
virus, the samples were freeze-thawed three times in liquid nitrogen and a 37°C water bath fol-
lowed by sonication for one minute. For virus quantification using a standard plaque assay,
virus was added to monolayers of BSC1 cells by serial dilution in triplicate. After one hour of
infection with each dilution, the BSC1 cells were rinsed twice with 1x PBS, and then incubated
with fresh complete medium containing 1% carboxymethylcellulose (low viscosity; Sigma-Al-
drich) for 2 to 5 days (2 days for VACV and 5 days for ECTV). Plaques from each dilution
were observed following a crystal violet stain of the monolayers.
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Fluorescence microscopy
Fluorescent microscopy for immunofluorescence was carried out using a Zeiss Axiostar plus
epifluorescent microscope and images were captured with an Optronics camera system. Cells
were grown on sterile glass coverslips, infected (MOI = 5) with ECTV, and fixed at the indicat-
ed time points with 10% formalin for 10 min at room temperature. For virus factory analysis,
cells were then immediately mounted on a glass slide with ProLong Gold antifade reagent with
4’-6-diamidino-2-phenylindole (DAPI; Life Technologies) and allowed to cure overnight prior
to visualization. For surface B5 staining, unpermeabilized cells were incubated—after fixation—
in blocking buffer [1% bovine serum albumin (BSA; Gemini BioProducts) and 2% FBS (Gemini
BioProducts) in 1x PBS] for 20 min and then incubated for 40 min with anti-B5 monoclonal
antibody (BEI resources NR-553) diluted in blocking buffer. After three washes with 1x PBS,
Alexa Fluor 568 goat anti-Mouse IgG1 (Life Technologies) diluted in blocking buffer was ap-
plied to cells for 20 min. Finally, the coverslips were mounted as described above on a glass
slide with ProLong Gold antifade reagent with DAPI. A Leica DM-IL LED inverted epifluores-
cent microscope was used to visualize fluorescence from VACVΔE3LΔK3L infected cells.
These images were then processed using QImaging software.
Western Blot analyses
Wild-type RK13 or RK13+E3L+K3L cells were grown overnight in 6-well plates before being
mock infected or infected with various VACV strains at an MOI of 5. Total protein lysates
were collected at 6 hours post-infection using 1% SDS in PBS and then sonicated. A total of
20μg of protein for each sample was separated on a 10% SDS-PAGE gel and blotted onto a
0.45μm polyvinyl difluoride (PVDF) membrane. Membranes were incubated with rabbit phos-
phospecific antibodies directed against Ser51 in eIF2α (BioSource International) or polyclonal
rabbit anti-eIF2α (Santa Cruz Biotechnology) antibodies followed by incubation with goat
anti-rabbit IgG, IgM, IgA antibodies conjugated to horseradish peroxidase (Open Biosystems).
Specific binding was detected using enhanced chemiluminescence and mean band intensities
were quantified with the Kodak Image Station 4000MM software. The ratios of phosphorylated
eIF2α to total eIF2α for each sample were calculated from two independent western blots and
the average ratios and standard deviations were determined using Microsoft Excel.
Flow cytometry
Flow cytometry data was collected using a FACSCalibur instrument (BD Biosciences) equipped
with both a red and blue laser. The collected data were analyzed using FCS Express 4 Flow Cy-
tometry (De Novo Software; version 4.07). In experiments examining the spread of virus,
5×105 cells were seeded into six-well plates. After the cells adhered to the surface, they were in-
fected (MOI = 0.01) with GFP-expressing ECTV or VACV as described above. After 24, 48, or
72 hours, the cells were harvested using trypsin digestion. Virus spread in the culture was quan-
tified by measuring the percentage of total cells that were positive for GFP expression. To mea-
sure surface expression of B5 protein, anti-B5 monoclonal antibody (BEI resources NR-553)
was added to cells that had been harvested using trypsin treatment and washed twice with 1x
PBS containing 1% BSA (Gemini BioProducts). After 30 minutes of incubation at room tem-
perature, the cells were washed once followed by the addition of anti-mouse IgG FITC
(eBioscience) for another 30 minutes. Next, to measure intracellular expression of E3 protein,
cells were permeabilized using the Cytofix/Cytoperm kit (BD Biosciences) according to the
manufacturer’s instructions. After permeabilization, anti-E3 monoclonal antibody (BEI re-
sources NR-4547) was added to the cells. After 30 minutes of incubation at room temperature,
the cells were washed once with Perm/Wash Buffer (BD Biosciences) followed by the addition
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of anti-mouse IgG2a APC (eBioscience) for an additional 30 minutes. Levels of phosphorylated
eIF2α were measured in permeabilized cells (approximately 12 hours post-infection) using a
monoclonal antibody (Abcam) that recognizes phosphorylated serine at amino acid residue
#51; the secondary antibody used in these experiments was DyLight 488 (Abcam).
Results
RK13 cells do not support robust replication of ECTV
The major goal of this study was to determine the viral factors(s) that influence the ability of
ECTV to replicate in cells derived from non-murine species. For example, ECTV replicates robust-
ly in BSC1 cells (African green monkey origin) and forms clearly defined plaques on monolayers
of these cells by day 5 post-infection (Fig. 1). Conversely, ECTV does not form plaques on mono-
layers of RK13 cells [European rabbit (Oryctolagus cuniculus) origin] within the same time frame
(Fig. 1). For this part of the study, ECTV expressing GFP was used to track the progress of infected
cells over time. We observed the formation of small GFP-positive foci, but these did not “open up”
to become a plaque in the classical sense of the term—even when the infection was allowed to pro-
ceed to day 7 (data not shown). Interestingly, the closely related VACV does readily form plaques
in both BSC1 and RK13 cells (data not shown). Therefore, ECTV appears to replicate inefficiently
in RK13 cells and demonstrates greatly reduced ability to spread among cells in culture.
Ectopic expression of VACV E3 and K3 rescues the replication of
VACVΔE3LΔK3L in RK13 cells
As stated earlier, E3 and K3 are known to be important host range factors for various poxvi-
ruses. Since VACV can productively infect RK13 cells while ECTV cannot, we speculated that
Fig 1. ECTV does not form plaques on RK13 cells.Monolayers of BSC1 and RK13 cells were initially
infected with a low amount of ECTV-GFP (MOI = 0.001). On day 5 post-infection, the monolayers were
examined for the formation of plaques. As expected, ECTV formed plaques on BSC1 cells (a representative
example is shown on the bottom row). However, no plaque formation was observed on RK13 cells (a
representative example is shown on the top row). All images are at 100x total magnification.
doi:10.1371/journal.pone.0119189.g001
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the presence of E3 and K3 from VACV in these cells may allow ECTV to replicate efficiently.
Additionally, other work from us suggests that VACV K3 is a potent inhibitor of European rab-
bit PKR (Peng and Rothenburg unpublished observation; manuscript in preparation). There-
fore, because ECTV lacks a functional K3L ortholog, we hypothesized that ECTV replication in
rabbit cells might be aided by the presence of VACV K3.
We made use of two different cell lines, RK13+E3L and RK13+E3L+K3L, that were devel-
oped and used for a previously published work [27]. These cell lines constitutively express
VACV E3 and K3 proteins (data not shown). As proof of concept, we tested the ability of the
RK13+E3L+K3L cells to rescue the replication of a mutant VACV (Copenhagen strain back-
ground; the virus contains GFP in the E3L locus) that has deletions in both the E3L and K3L
genes [29]. The parent virus (wild type VACV-Copenhagen) produced large plaques in both
RK13 wild type cells and those stably expressing E3L and K3L (Fig. 2A). However, the double-
mutant (VACVΔE3LΔK3L) was only able to produce observable plaques in the RK13+E3L+
K3L cells (Fig. 2A). The presence of E3L and K3L in these cells also allowed the formation of
GFP-positive plaques after infection with the VACVΔE3LΔK3L virus, which indicates this
virus is able to replicate in these cells. In agreement with the observed fluorescence and cyto-
pathic effect, infection of wild-type RK13 cells with the wild-type VACV yielded a significantly
higher virus titer than VACVΔE3LΔK3L, which was unable to replicate above the level of input
virus (104 pfu/mL; Fig. 2B). Viral replication of wild-type VACV in the RK13+E3L+K3L cells
was repeatedly observed to be significantly reduced compared to replication in the wild-type
RK13 cells, which may be due to a slower growth of these cells compared to the unmanipulated
RK13 cells. Notably, significant replication of VACVΔE3LΔK3L occurred in RK13+E3L+K3L
cells (approximately 100-fold increase over input levels).
To determine the individual contributions of E3L and K3L to VACV replication in RK13
cells, we used two additional mutant VACV strains that have deletions in either E3L or K3L
alone (both viruses are Copenhagen strain background; the E3L deleted virus contains GFP in
Fig 2. Growth of VACVΔE3LΔK3L is restored in RK13 cells expressing VACV E3 and K3 proteins. (A) VACVΔE3LΔK3L was constructed using
homologous recombination techniques and engineered to express GFP in place of the E3L gene. No plaque formation was visualized in wild-type RK13 cells
whereas replication capacity was restored in RK13 cells stably expressing E3 and K3 proteins derived from VACV. Representative images are shown. (B)
The total yield of VACV wild-type, VACVΔE3L, VACVΔK3L, and VACVΔE3LΔK3L was determined using wild-type RK13 (red bars) and RK13+E3L+K3L
(gray bars) cells. Cells were initially infected with a low amount of virus (MOI = 0.01). Virus was harvested 30 hours post-infection and the total yield was
determined using standard plaque assays with RK13+E3L+K3L cells. The data is the average of two independent experiments with error bars representing
the standard deviation. P-values were determined in Microsoft Excel using the Student’s t-test.
doi:10.1371/journal.pone.0119189.g002
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the E3L locus) and compared their replication to that of wild-type VACV and VACVΔE3LΔK3L
(Fig. 2B). The VACVΔE3L virus replicated to significantly lower titers than wild-type VACV
in RK13 wild-type cells, although still much higher than VACVΔE3LΔK3L (approximately
90-fold higher). VACVΔK3L, on the other hand, reached titers similar to wild-type VACV and
replicated significantly better than VACVΔE3LΔK3L in these cells. In the RK13+E3L+K3L
cells, both the VACVΔE3L and VACVΔK3L viruses were able to replicate similarly to the wild-
type VACV, however, we consistently observed that replication of both the VACVΔE3LΔK3L
and VACVΔE3L viruses in RK13+E3L+K3L cells was lower than that of wild type VACV
(around 10-fold lower), although these differences were not statistically significant. It is possi-
ble that expression of E3L from the RK13+E3L+K3L cells may not be as high as during virus
infection and higher expression of E3L is required to fully complement its deletion from
the virus.
Ectopic expression of VACV E3 and K3 suppresses ECTV- and VACV-
induced phosphorylation of eIF2α
E3L and K3L protein products are inhibitors of the cellular PKR pathway and their expression
is required to inhibit the phosphorylation of eIF2α by PKR following VACV infection in RK13
cells (Fig. 3A and 3B). In wild-type RK13 cells, infection with VACVΔE3LΔK3L resulted in in-
creased PKR activity as indicated by the higher levels of phosphorylated eIF2α whereas the
wild-type VACV was able to inhibit most of this activity (Fig. 3A; top panel, compare the first
and second lanes). This inhibition was further pronounced in the RK13+E3L+K3L cells for the
wild-type VACV as no increase in eIF2α phosphorylation was observed relative to the unin-
fected cells. It is notable that the overall levels of phosphorylated eIF2α are lower in the RK13+
E3L+K3L cells, which is most likely due to the activity of E3L and K3L. However, their expres-
sion in these cells was not able to completely inhibit the phosphorylation of eIF2α during infec-
tion with VACVΔE3LΔK3L (Fig. 3A; lane 7 vs. lane 8), which may explain the slight reduction
in replication observed for this virus in the RK13+E3L+K3L cells compared to the wild-type.
Nevertheless, the proportion of phosphorylated eIF2α relative to total eIF2α never exceeded
that seen in the wild-type RK13 cells infected with wild-type VACV (Fig. 3B). These data sug-
gest that the virus is still able to replicate successfully below a certain threshold for PKR activi-
ty, which is prevented from being reached following infection with VACVΔE3LΔK3L due
to the activity of E3L and K3L in the RK13+E3L+K3L cells. Overall, we observed a negative
correlation between the levels of phosphorylated eIF2α and the replicative ability of the VACV
strains.
In a series of complementary experiments, we used flow cytometry to measure levels of
phosphorylated eIF2α after infection with VACVΔE3LΔK3L. Consistent with the western blot
results described above, this mutant virus induced robust phosphorylation of eIF2α in wild-
type RK13 cells (Fig. 3C), which was inhibited in RK13+E3L+K3L cells (Fig. 3D). After infec-
tion with ECTV, there was a small but reproducible increase in phosphorylated eIF2α in wild-
type RK13 (Fig. 3C) but not in RK13+E3L+K3L cells (Fig. 3D). The presence of measurable
eIF2α phosphorylation after ECTV infection of wild-type RK13 cells may be related to the fact
that ECTV does not have a functional K3L gene—and seemingly relies solely on E3L—while
VACV does maintain a functional copy of K3L.
Ectopic expression of VACV E3 and K3 does not enable productive
ECTV infection of RK13 cells
In our next series of experiments, we measured the ability of VACV and ECTV to spread in
cultured cells after infection with a low initial inoculum (MOI = 0.01). We used BSC1 cells as a
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positive control for both viruses. VACV infection spread efficiently in all tested cell lines over
the course of a three day period (Fig. 4A and 4B) and ECTV displayed a similar ability to
spread in BSC1 cells (Fig. 4C and 4D). Interestingly, there was no measureable difference in the
replication of ECTV in any of the RK13 lines (Fig. 4C and 4D). We also conducted single-cycle
growth curves as an additional means to assess virus replication. The yield of VACV was indis-
tinguishable in all cell lines as before (Fig. 4E). ECTV demonstrated significantly greater repli-
cation in BSC1 cells compared to all RK13 lines (Fig. 4F). Moreover, there was no detectable
difference in the extent of replication of ECTV in wild-type RK13 compared to the cells that
constitutively express E3 by itself or with K3 (Fig. 4F).
Fig 3. ECTV- and VACV-induced phosphorylation of eIF2α in RK13 cells. (A)Wild-type RK13 or RK13+E3L+K3L cells were mock infected or infected
with the indicated VACV strains at an MOI of 5. Cell lysates were collected 6 hours post infection and subjected to SDS-PAGE and immunoblot analysis.
Membranes were first probed with antibodies against eIF2α phosphorylated at Ser51 (eIF2α-P; top row), stripped, and then re-probed with anti-eIF2α
antibodies (total eIF2α; bottom row). Band intensities were measured using the Kodak Image Station 4000MM and the ratios of phosphorylated eIF2α to total
eIF2α were calculated as a percentage and listed below the panels. (B) The average ratios of two independent western blots are indicated in the bar graph
with error bars indicating the standard deviation. (C and D)Wild-type RK13 (C) or RK13+E3L+K3L cells (D) were mock infected or infected with the indicated
viruses at an MOI of 5 for 12 hours at which time cells were collected, permeabilized, and stained for phosphorylated eIF2α. The histograms depict relative
fluorescence intensity among total cells and are representative of three independent trials.
doi:10.1371/journal.pone.0119189.g003
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Fig 4. The replication of ECTV is reduced in RK13 compared to BSC1 cells even when VACV E3L and K3L are present during infection. BSC1 (black
bars), RK13 (red bars), RK13-E3L (blue bars), and RK13-E3L+K3L (gray bars) cells were initially infected with a low amount of VACV-GFP (MOI = 0.01) (A
and B) or ECTV-GFP (MOI = 0.01) (C and D). Spread of virus in the culture well was quantified using flow cytometry. The histograms (A and C) depict
relative fluorescence intensity among total cells at day 3 post-infection. The bar graphs (B and D) quantify levels of GFP on days 1, 2, and 3 post-infection in
each cell type. The bars depict the average values and the error bars represent the standard deviations of three independent trials. The yield of w.t. VACV (E)
and ECTV (F) was determined 48 hours after initial infection with a high amount of virus (MOI = 5) on cell monolayers. For quantification using a standard
plaque assay, harvested virus was added to monolayers of BSC1 cells after serial dilution. The bars depict the average values and the error bars represent
the standard deviations of three independent trials. Statistical analysis [performed using GraphPad Prism software (version 5.0a)] was carried out using a
one-way ANOVA (nonparametric; Kruskal-Wallis) followed by a Dunns test for multiple comparisons. * denotes a p value<0.05.
doi:10.1371/journal.pone.0119189.g004
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ECTV experiences an abortive infection in RK13 cells
Based on our data in this study, it appears that ECTV essentially does not complete its full rep-
lication cycle in RK13 cells. To investigate this further, we determined where in the viral repli-
cation cycle the apparent block occurs. First, we stained uninfected and infected cells with
DAPI, which stains double-stranded DNA, to label host cell nuclei and to detect the presence
of virus factories. Poxviruses display an entirely cytoplasmic replication cycle and, therefore,
virus factories can be visualized with DAPI staining after viral DNA replication has occurred
[30]. After a 24 hour infection (MOI = 5) with ECTV, virus factories were clearly discernable
in BSC1 cells, which served as the positive control (Fig. 5A). In the three RK13 lines, cyto-
plasmic DAPI staining was observed in some cells but the relative size of the virus factories was
noticeably smaller as compared to factories seen in BSC1 cells (Fig. 5A). Upon quantification
(Fig. 5B), a significantly higher proportion of infected BSC1 cells (approaching 100%) con-
tained virus factories compared to the infected RK13 lines (approximately 65% on average).
Next, using fluorescent microscopy in conjunction with flow cytometry, we stained ECTV-
infected cells for the presence of intracellular E3 (early gene product) and surface (non-per-
meabilized) expression of B5 protein, which is indicative of the presence of cell-associated/
extracellular enveloped virus particles [31,32]. It should be noted that while the anti-B5 and
anti-E3 antibodies were originally raised against the VACV version of these proteins, both anti-
bodies are cross-reactive with the ECTV B5 and E3 homologues, respectively (data not shown).
As shown in Fig. 6A, we could readily detect B5 on ECTV-infected BSC1 cells but very little on
any of the RK13 lines. We then used flow cytometry to quantify cell surface levels of the B5 pro-
tein. A large fraction (75%) of BSC1 cells stained positive for B5 at 24 hours post-infection,
whereas only a limited number (5%) of RK13 cells were positive for B5 (Fig. 6B; representative
results are shown for only the wild-type RK13 cells but similar results were also obtained for the
RK13+E3L and E3L+K3L lines). Thus, the block in ECTV replication in RK13 cells appears to
occur sometime before the formation of mature enveloped virions at the cell surface.
Fig 5. Virus factory formation during ECTV infection is more robust in BSC1 compared to RK13 cells. (A) Cells were grown on sterile glass coverslips,
infected (MOI = 5) with ECTV, and fixed 24 hours later. Cell nuclei (N) and virus factories (F) were visualized following DAPI staining. Representative images
are shown for both uninfected and infected cells. All images are at 1,000x total magnification. (B)One hundred randomly viewed cells within each infection
condition were scored as either being positive or negative for the presence of a virus factory as compared to the uninfected control. The bars depict the
average values and the error bars represent the standard deviations of three independent trials. Statistical analysis [performed using GraphPad Prism
software (version 5.0a)] was carried out using a one-way ANOVA (nonparametric; Kruskal-Wallis) followed by a Dunns test for multiple comparisons. *
denotes a p value<0.05.
doi:10.1371/journal.pone.0119189.g005
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Finally, we measured intracellular levels of E3 protein in ECTV-infected cells as a surrogate
marker of early gene expression. As depicted in Fig. 6B, nearly 100% of all BSC1 and wild-type
RK13 cells expressed ECTV-E3 protein at 24 hours post-infection (note that E3 staining is not
shown for the RK13+E3L and E3L+K3L lines because both constitutively express high levels of
VACV-E3 protein, even in uninfected cells). Overall, these data indicate that ECTV can enter
and begin early gene expression in RK13 cells, but other downstream replication events, such
as DNA replication or egress of enveloped virions, are significantly restricted or blunted (Figs.
5 and 6).
Discussion
An interesting feature of viruses in the subfamily Chordopoxvirinae is that even closely-related
species of the same genus can vary substantially in the range of host species that can be produc-
tively infected [11,13]. For example, ECTV and VACV are two members of the genus Ortho-
poxvirus that display disparate host range characteristics. In this work, we focused on the two
previously identified VACV host range genes, E3L and K3L. The protein products of these
genes are both involved in interfering with various segments of the host cell PKR pathway [16].
To give an indication of the importance of either E3L or K3L, prior work has shown that
knocking out either from the VACV genome renders the virus incapable of replicating in some
cell types [18].
Fig 6. Late replication cycle events and cell surface virion assembly of ECTV are diminished in RK13 cells. (A) Cells were grown on sterile glass
coverslips, infected (MOI = 5) with ECTV, fixed 24 hours later, and then stained for the presence of cell surface B5 protein. Representative images are shown
only for infected conditions because staining of uninfected control cells yielded no detectable signal. All images are at 400x total magnification. (B) Cells,
which had been infected (MOI = 5) for 24 hours with ECTV, were stained for surface B5 and intracellular E3 following the protocol outlined in the Methods
section. All data shown are representative of three independent experiments.
doi:10.1371/journal.pone.0119189.g006
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Our data show that ECTV is unable to productively replicate in European rabbit RK13 cells
in culture. Conversely, VACV can replicate efficiently in these cells. Therefore, we sought to
determine if VACV E3L could rescue the replication defect of ECTV in RK13 cells. While the
VACV and ECTV versions of E3 are highly related, the amino acid sequences are not
completely conserved. Therefore, it is formally possible that one ortholog of E3 could be more
functional in certain cell types compared to the other. Additionally, many poxviruses, includ-
ing VACV, encode for a K3 ortholog. Interestingly, ECTV does not possess an intact K3L gene
due to the presence of a premature stop codon and frame shift-causing deletions in the open
reading frame, thus yielding a predicted truncated form of the expressed protein [12,19,25].
Since ECTV does not produce a functional K3L protein product, we hypothesized that the
presence of VACV K3L in RK13 cells could then allow for the productive infection of these
cells by ECTV.
Despite our initial predictions, the data presented in this study do not show a detectable role
for either VACV E3L or K3L in improving the ability of ECTV to productively infect RK13
cells. In several assays, we failed to observe any significant differences with respect to the repli-
cation of ECTV in wild-type RK13 compared to versions of this cell line that stably express
VACV E3 alone or with K3. Given that unpublished data has shown that K3L from VACV is a
potent inhibitor of European rabbit PKR (Peng and Rothenburg; manuscript in preparation),
these results were somewhat surprising. This indicates that ineffective PKR inhibition by
ECTV is likely not involved in restricting its replication in RK13 cells. Meanwhile, we con-
firmed that E3L and K3L are required for VACV replication in RK13 cells as the VACV-
ΔE3LΔK3L virus is unable to replicate in these cells, but can replicate efficiently in RK13 cells
stably expressing these two viral genes.
The individual role of each viral inhibitor was further assessed with single deletion mutants
of VACV, which showed that VACVΔE3L was slightly more attenuated than VACVΔK3L in
wild-type RK13 cells. Because of this, we reasoned that while both E3L and K3L are important
for VACV replication in RK13 cells, E3L may be of greater importance to virus replication in
these cells. VACV expression of E3L in the absence of K3L is sufficient to allow VACV replica-
tion in wild-type RK13 cells, whereas K3L alone enables only moderate virus replication. While
PKR inhibition likely does not play a role in the failure of ECTV to replicate in RK13 cells, K3L
and E3L are both important for suppressing PKR phosphorylation of eIF2α during VACV in-
fection. Indeed, our results show that the successful replication of VACVΔE3LΔK3L in the
RK13+E3L+K3L cells is most likely due to the activity of the E3L and K3L gene products,
which suppress PKR activation below a certain threshold that would otherwise prevent
virus replication.
There is an ordered cascade of events that take place in a cell after infection with a poxvirus.
First, early genes are expressed, followed by DNA replication, then late gene expression, and fi-
nally virus assembly [33]. Our data indicate that the addition of ECTV to RK13 cells largely re-
sults in an abortive infection. We provide evidence to suggest that ECTV entry is not impaired
during infection of RK13 cells nor is early gene expression compromised. However, DNA repli-
cation is somewhat diminished as revealed by the significantly lower frequency of observed cy-
toplasmic virus factories. Furthermore, we find that the formation of enveloped virus particles
at the cell surface—as measured by staining for B5 [31,32,34]—is severely blunted in RK13
cells. Therefore, a host factor (or factors) in rabbit cells is likely having a negative impact on the
ability of ECTV to replicate its genome and form mature enveloped virions at the cell surface.
Furthermore, it is also conceivable that the expression of viral late genes is inhibited but this
possibility was not formally examined in this study.
To our knowledge, only one published paper to date [26] has shown a rescue of ECTV in
RK13 cells. In this study, insertion of the Chinese hamster ovary host range gene (CHOhr/CP77)
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from cowpox virus into the ECTV genome extended its host range in tissue culture. This re-
combinant ECTV was shown to replicate more efficiently in both CHO and RK13 cells com-
pared to wild-type virus [26]. In our study, we attempted to identify other poxvirus genes that
would also endow ECTV with the capacity to replicate productively in RK13 cells. We discov-
ered that the expression of VACV E3L and K3L in the RK13 cell line does not improve the rep-
lication capacity of ECTV. Compared to cowpox virus or VACV, ECTV has a narrow host
range. In fact, the mouse is the only known host of ECTV [35]. Therefore, there are many un-
answered questions related to the factor(s) that limit the host range of ECTV. Further studies
are required to determine if other poxvirus gene(s) besides CHOhr/CP77 [26] can improve the
ability of ECTV to replicate in cells derived from non-murine species.
The study of the viral and cellular events related to the host range of poxviruses is an impor-
tant endeavor. For instance, poxviruses are important vaccine vectors [36,37] and have also
shown promise as an anti-cancer therapy [38]. Additionally, there has been a recent surge in
the number of human monkeypox infections in various parts of the world [39]. Therefore, the
scientific and medical communities would benefit from an increased understanding of how
poxviruses replicate in different cell types and the factors that limit replication in certain
host species.
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